Published • loading... • Updated
CRIS Against Cancer Promotes Pragmatic Clinical Trials to Reduce Toxicity and Customize Treatments - Correspondents
Summary by Corresponsables.com España
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Read a quick summary generated by AI × Summary of the news: CRIS Against Cancer highlights, on International Clinical Trial Day, the importance of pragmatic clinical trials to improve existing treatments and reduce toxicities. Since 2022, the entity has allocated more than 2 million euros to fund international trials with the Institut Gustave Roussy, with projects in breast, lung, kidney, leukemia and neuroendocrine tumors. These studies seek to…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
